In India, a temporary ban on cough syrups has been imposed following the deaths of at least fourteen children in the states of Maharashtra and Madhya Pradesh over the past month. This was reported by Zamin.uz.
The children initially showed symptoms of a cold, but later their condition worsened, with cases of kidney failure and loss of consciousness being identified. The banned syrups were found in the children's homes and, after safety inspections, their sale was halted.
Experts suggest that poisoning or the rare Chandipura virus could be the cause in these syrups. Currently, a total of twenty-two batches of syrup are under ban.
In Rajasthan state, several children also died after consuming these syrups, and even a doctor lost consciousness after drinking the syrup to test its safety. It was reported that in Uzbekistan in 2022, 69 children died due to the Indian-made "Dok-1 Max" cough syrup.
For this reason, control over medications that may harm children has been strengthened. This incident highlights the necessity of paying special attention to the quality and safety of medicines in protecting public health.
Additional inspections are being conducted by the relevant authorities regarding the current situation, and the public is advised to increase awareness measures.
